Literature DB >> 9564556

Proteinases and proteinase inhibitors during the development of pulmonary fibrosis in rat.

R Koslowski1, K P Knoch, K W Wenzel.   

Abstract

Changes in the activities of several proteinases and their inhibitors were investigated during the development of bleomycin-induced pulmonary fibrosis in rat. Studies on the proteinase-anti-proteinase-ratio may contribute to the understanding of the mechanism of the development of pulmonary fibrosis and may help to develop therapeutic strategies to prevent tissue damage by proteolytic attack. In the acute inflammatory period the activity of metalloelastase in lung tissue increased by about 10-fold. The time course of changes in the activity of 72 kD gelatinase indicates that this gelatinase accounts at least partially for the elastolytic activity. Elastase inhibitory activity in lung tissue showed maxima at days 1 and 5 and high levels in the fibrotic phase. The increase of the elastase inhibitory activity at the beginning of the fibrotic period corresponds with elevated activity of alpha 2-macroglobulin. Alveolar fluid and alveolar macrophages did not contain elastase activity but contained high elastase inhibitory activity. During the period of chronic inflammation, the activities of the cathepsins L, B, H and S in lung tissue and in isolated alveolar macrophages were found to be strongly increased.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9564556     DOI: 10.1016/s0009-8981(97)00228-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury.

Authors:  Hiroshi Hirakawa; Richard A Pierce; Gulbin Bingol-Karakoc; Cagatay Karaaslan; Meiqian Weng; Guo-Ping Shi; Ali Saad; Ekkehard Weber; Thomas J Mariani; Barry Starcher; Steve D Shapiro; Sule Cataltepe
Journal:  Am J Respir Crit Care Med       Date:  2007-08-02       Impact factor: 21.405

2.  Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo.

Authors:  K Menzel; M Hausmann; F Obermeier; K Schreiter; N Dunger; F Bataille; W Falk; J Scholmerich; H Herfarth; G Rogler
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

3.  The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.

Authors:  C M Swaisgood; E L French; C Noga; R H Simon; V A Ploplis
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

4.  Cathepsin D is up-regulated in inflammatory bowel disease macrophages.

Authors:  M Hausmann; F Obermeier; K Schreiter; T Spottl; W Falk; J Schölmerich; H Herfarth; P Saftig; G Rogler
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

5.  Expression profiling of genes regulated by Fra-1/AP-1 transcription factor during bleomycin-induced pulmonary fibrosis.

Authors:  Subbiah Rajasekaran; Narsa M Reddy; Wei Zhang; Sekhar P Reddy
Journal:  BMC Genomics       Date:  2013-06-07       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.